IT1195304B
(it)
|
1981-12-22 |
1988-10-12 |
Anic Spa |
Metodo per la preparazione di gem-diammino derivati n-monoacilati
|
US4631211A
(en)
*
|
1985-03-25 |
1986-12-23 |
Scripps Clinic & Research Foundation |
Means for sequential solid phase organic synthesis and methods using the same
|
US4698327A
(en)
*
|
1985-04-25 |
1987-10-06 |
Eli Lilly And Company |
Novel glycopeptide derivatives
|
US4980286A
(en)
|
1985-07-05 |
1990-12-25 |
Whitehead Institute For Biomedical Research |
In vivo introduction and expression of foreign genetic material in epithelial cells
|
IT1190389B
(it)
*
|
1985-09-19 |
1988-02-16 |
Eniricerche Spa |
Esapeptidi ad attivita' ipotensiva
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
US5169933A
(en)
*
|
1988-08-15 |
1992-12-08 |
Neorx Corporation |
Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
|
IT1227907B
(it)
|
1988-12-23 |
1991-05-14 |
Eniricerche S P A Milano Sclav |
Procedimento per la sintesi di peptidi retro-inversi e nuovi intermediin tale procedimento
|
JP2752788B2
(ja)
|
1989-01-23 |
1998-05-18 |
カイロン コーポレイション |
感染および過剰増殖障害の為の組換え療法
|
GB8919607D0
(en)
|
1989-08-30 |
1989-10-11 |
Wellcome Found |
Novel entities for cancer therapy
|
US6316003B1
(en)
*
|
1989-12-21 |
2001-11-13 |
Whitehead Institute For Biomedical Research |
Tat-derived transport polypeptides
|
US5804604A
(en)
|
1989-12-21 |
1998-09-08 |
Biogen, Inc. |
Tat-derived transport polypeptides and fusion proteins
|
US5674980A
(en)
|
1989-12-21 |
1997-10-07 |
Biogen Inc |
Fusion protein comprising tat-derived transport moiety
|
US5840313A
(en)
*
|
1990-09-27 |
1998-11-24 |
Syntello Vaccine Development Kb |
Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
|
WO1992018138A1
(en)
|
1991-04-10 |
1992-10-29 |
The General Hospital Corporation |
Mammalian gap-43 compositions and methods of use
|
US5994108A
(en)
*
|
1991-11-05 |
1999-11-30 |
Board Of Regents, The University Of Texas System |
Mutant TAR virus and transdominant tat mutants as pharmacological agents
|
US5350835A
(en)
*
|
1991-11-05 |
1994-09-27 |
Board Of Regents, University Of Texas |
Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids
|
CA2131620A1
(en)
|
1992-03-20 |
1993-09-30 |
Louis C. Smith |
A dna transporter system and method of use
|
ES2221920T3
(es)
*
|
1992-04-03 |
2005-01-16 |
The Regents Of The University Of California |
Sistema de liberacion de polinucleotidos de autoensamblaje que comprende un peptido cationico anfipatico.
|
EP0673385A4
(de)
|
1992-08-13 |
1995-11-29 |
Gen Hospital Corp |
Zusammensetzungen aus menschlichem gap-43 und verfahren für ihre verwendung.
|
DK0656950T3
(da)
|
1992-08-21 |
1999-07-19 |
Biogen Inc |
TAT-afledte transportpolypeptider
|
CA2143823C
(en)
|
1992-08-27 |
2005-07-26 |
Alfio Comis |
Retro-, inverso - and retro-inverso synthetic peptide analogues
|
US5545551A
(en)
*
|
1992-08-28 |
1996-08-13 |
Mt. Sinai School Of Medicine Of The City University Of New York |
Cloning and expression of pur protein
|
WO1994008598A1
(en)
|
1992-10-09 |
1994-04-28 |
Advanced Tissue Sciences, Inc. |
Liver reserve cells
|
EP0693939A1
(de)
|
1993-04-14 |
1996-01-31 |
Roche Diagnostics GmbH |
Nukleinsäure-transferpeptide und deren verwendung zur einschleusung von nukleinsäuren in eukaryontische zellen
|
CA2153480A1
(en)
|
1993-11-12 |
1995-06-01 |
Kenichi Matsubara |
Gene signature
|
US5807746A
(en)
|
1994-06-13 |
1998-09-15 |
Vanderbilt University |
Method for importing biologically active molecules into cells
|
CA2193354A1
(en)
|
1995-04-25 |
1996-10-31 |
Catherine Lee |
Composition containing collagenase and chymopapain for isolating hepatocytes and pancreatic islet cells
|
BR9610058A
(pt)
|
1995-07-28 |
1999-07-27 |
Marie Curie Cancer Care |
Uso de vp22 ou uma porção ativa fragmento ou homólogo do mesmo proteína de transporte ácido nucleíco vetor de expressão célula hospedeira de mamíferos ou microbiana e processos para transportar uma proteína ou peptídeo desejado para uma população de marcaç o de células e para transportar uma molécula desejada em uma população de células
|
WO1997010836A1
(en)
|
1995-09-21 |
1997-03-27 |
Innapharma, Inc. |
Peptides and peptidomimetics inhibiting the oncogenic action of p21 ras
|
IE80466B1
(en)
*
|
1995-11-10 |
1998-07-29 |
Elan Corp Plc |
Peptides which enhance transport across tissues and methods of identifying and using the same
|
US5877282A
(en)
|
1996-09-20 |
1999-03-02 |
Bristol-Myers Squibb Company |
Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
|
US6187817B1
(en)
*
|
1996-10-03 |
2001-02-13 |
Southern Illinois University School Of Medicine |
Therapeutic use of d-methionine to reduce the toxicity of platinum-containing anti-tumor compounds
|
US6361938B1
(en)
|
1996-11-08 |
2002-03-26 |
Elan Corporation, Plc |
Peptides which enhance transport across tissues and methods of identifying and using the same
|
WO1998023781A1
(en)
|
1996-11-26 |
1998-06-04 |
Johns Hopkins University |
Ligand detection system and methods of use thereof
|
US5989814A
(en)
*
|
1997-04-01 |
1999-11-23 |
Reagents Of The University Of California |
Screening methods in eucaryotic cells
|
US5880261A
(en)
|
1997-04-03 |
1999-03-09 |
Waeber; Gerard |
Transcription factor Islet-Brain 1 (IB1)
|
WO1998047913A2
(en)
|
1997-04-18 |
1998-10-29 |
The University Of Medicine And Dentistry Of New Jersey |
Inhibition of hiv-1 replication by a tat rna-binding domain peptide analog
|
US6043083A
(en)
|
1997-04-28 |
2000-03-28 |
Davis; Roger J. |
Inhibitors of the JNK signal transduction pathway and methods of use
|
WO1998051325A2
(en)
|
1997-05-15 |
1998-11-19 |
Cytogen Corporation |
Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
|
US20040152084A1
(en)
|
2003-01-31 |
2004-08-05 |
Slattum Paul M. |
Compounds and processes for single-pot attachment of a label to nucleic acid
|
BR9809138A
(pt)
|
1997-05-21 |
2001-08-28 |
Trustees For The Leland Stanfo |
Conjugado e método para aumentar o transporte de um composto selecionado atravessando uma membrana biológica
|
FR2767323B1
(fr)
|
1997-08-12 |
2001-01-05 |
Synt Em |
Peptides lineaires derives de peptides antibiotiques, leur preparation et leur utilisation pour vectoriser des substances actives
|
EP0897002A3
(de)
|
1997-08-14 |
2001-10-04 |
Smithkline Beecham Plc |
U62317, ein Protein mit einem JNK-bindendem Gebiet
|
WO1999016787A1
(en)
|
1997-09-26 |
1999-04-08 |
Washington University |
Cell death agonists
|
US6420031B1
(en)
|
1997-11-03 |
2002-07-16 |
The Trustees Of Princeton University |
Highly transparent non-metallic cathodes
|
CN1279682A
(zh)
|
1997-10-20 |
2001-01-10 |
霍夫曼-拉罗奇有限公司 |
双环激酶抑制剂
|
US6270956B1
(en)
*
|
1997-12-11 |
2001-08-07 |
The Salk Institute For Biological Studies |
Transcriptional coactivator that interacts with Tat protein and regulates its binding to TAR RNA, methods for modulating Tat transactivation, and uses therefor
|
EP0947524A1
(de)
|
1998-03-30 |
1999-10-06 |
Upither B.V. |
Neue Peptide zur Behandlung von Autoimmunkrankheiten
|
US6248558B1
(en)
|
1998-03-31 |
2001-06-19 |
Vanderbilt University |
Sequence and method for genetic engineering of proteins with cell membrane translocating activity
|
WO1999055682A1
(en)
|
1998-04-29 |
1999-11-04 |
Georgetown University |
Methods of identifying and using hla binding compounds as hla-agonists and antagonists
|
AU4184299A
(en)
*
|
1998-05-13 |
1999-11-29 |
Incyte Pharmaceuticals, Inc. |
Human apoptosis associated proteins
|
WO1999058561A1
(fr)
|
1998-05-14 |
1999-11-18 |
Pasteur Merieux Serums & Vaccins |
Mimotopes du virus de l'hepatite c
|
US6811992B1
(en)
|
1998-05-14 |
2004-11-02 |
Ya Fang Liu |
Method for identifying MLK inhibitors for the treatment of neurological conditions
|
WO1999066061A1
(fr)
*
|
1998-06-18 |
1999-12-23 |
Dnavec Research, Inc. |
Phage de transfert d'acide nucleique
|
JP2002518521A
(ja)
*
|
1998-06-20 |
2002-06-25 |
ワシントン・ユニバーシティ |
医用画像解析、診断および治療のための膜透過性ペプチド錯体
|
US6589503B1
(en)
|
1998-06-20 |
2003-07-08 |
Washington University |
Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
|
DK1400551T3
(da)
|
1998-08-28 |
2007-10-15 |
Amylin Pharmaceuticals Inc |
Polyamidkæder med præcis længde og deres konjugater med proteiner
|
ES2288042T3
(es)
*
|
1998-09-25 |
2007-12-16 |
Cephalon, Inc. |
Uso de pirrolocarbazoles condensados para prevenir/tratar daños de las celulas ciliadas sensoriales y neuronas cocleares.
|
US6656474B1
(en)
|
1999-01-15 |
2003-12-02 |
Regeneron Pharmaceuticals, Inc. |
Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders
|
US6673908B1
(en)
|
1999-02-22 |
2004-01-06 |
Nuvelo, Inc. |
Tumor necrosis factor receptor 2
|
JP2003506071A
(ja)
|
1999-05-28 |
2003-02-18 |
アポプトシス テクノロジー,アイエヌシー. |
アポトーシスを制御する化合物および方法ならびにアポトーシスを制御する化合物を製造およびスクリーニングする方法
|
US7510824B2
(en)
*
|
1999-06-02 |
2009-03-31 |
Nono Inc. |
Method of screening peptides useful in treating traumatic injury to the brain or spinal cord
|
AU5316900A
(en)
*
|
1999-06-03 |
2000-12-28 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-jun n-terminal kinases (jnk)
|
DK1102785T3
(da)
*
|
1999-06-07 |
2013-05-13 |
Arrowhead Res Corp |
Sammensætninger til lægemiddeltilførsel ved anvendelse af pH-følsomme molekyler
|
AU769315B2
(en)
|
1999-08-24 |
2004-01-22 |
Cellgate, Inc. |
Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
|
US6669951B2
(en)
|
1999-08-24 |
2003-12-30 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into epithelial tissues
|
US20030104622A1
(en)
*
|
1999-09-01 |
2003-06-05 |
Robbins Paul D. |
Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
|
EP1210362A2
(de)
|
1999-09-01 |
2002-06-05 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Identifizierung von peptiden, die die aufnahme und den cytoplasmatischen und/oder kerntransport von proteinen, dna und viren erleichtern
|
US8183339B1
(en)
|
1999-10-12 |
2012-05-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
US6610820B1
(en)
*
|
1999-10-12 |
2003-08-26 |
University Of Lausanne |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
US20040082509A1
(en)
*
|
1999-10-12 |
2004-04-29 |
Christophe Bonny |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
US20030108539A1
(en)
*
|
2000-02-14 |
2003-06-12 |
Christophe Bonny |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
WO2001039784A1
(en)
|
1999-12-06 |
2001-06-07 |
The General Hospital Corporation |
Pancreatic stem cells and their use in transplantation
|
US6586403B1
(en)
*
|
2000-07-20 |
2003-07-01 |
Salpep Biotechnology, Inc. |
Treating allergic reactions and inflammatory responses with tri-and dipeptides
|
US6897231B2
(en)
*
|
2000-07-31 |
2005-05-24 |
Signal Pharmaceuticals, Inc. |
Indazole derivatives as JNK inhibitors and compositions and methods related thereto
|
US7033597B2
(en)
|
2000-10-13 |
2006-04-25 |
Université de Lausanne |
Intracellular delivery of biological effectors
|
JP4387669B2
(ja)
|
2000-10-13 |
2009-12-16 |
ザイジェン エス.アー. |
新規なトランスポーターペプチド配列による生物学的エフェクターの細胞内送達
|
AU1112202A
(en)
|
2000-10-17 |
2002-04-29 |
Diatranz Ltd |
Preparation and xenotransplantation or porcine islets
|
EP1364949A4
(de)
|
2001-02-02 |
2005-11-23 |
Takeda Pharmaceutical |
Jnk inhibitor
|
US20030077826A1
(en)
|
2001-02-02 |
2003-04-24 |
Lena Edelman |
Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC)
|
AU2002240312A1
(en)
|
2001-02-08 |
2002-08-19 |
Pankaj Paranjp |
Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agents using polymer conjugates
|
DE60233137D1
(de)
|
2001-02-16 |
2009-09-10 |
Univ R |
Transporter mit beabstandeten arginin-teilchen
|
DE10117281A1
(de)
|
2001-04-06 |
2002-10-24 |
Inst Molekulare Biotechnologie |
Peptid zur Diagnose und Therapie der Alzheimer-Demenz
|
ATE343591T1
(de)
|
2001-04-06 |
2006-11-15 |
Univ Jefferson |
Antagonist für die multimerisierung von hiv-1 vif-protein
|
AU2002322519A1
(en)
|
2001-07-17 |
2003-03-03 |
Incyte Genomics, Inc. |
Proteins associated with cell growth, differentiation, and death
|
EP1436291B1
(de)
|
2001-09-19 |
2009-01-14 |
Aventis Pharma S.A. |
Indolizine als kinaseproteinhemmer
|
JP2005525096A
(ja)
|
2002-01-09 |
2005-08-25 |
ユニバーシティ オブ ローザンヌ |
Jnkシグナル伝達経路の細胞浸透性ペプチドインヒビター
|
US7149215B1
(en)
*
|
2002-02-20 |
2006-12-12 |
Nortel Networks Limited |
Technique for multicasting receiver membership reports
|
AU2003217961B2
(en)
|
2002-03-08 |
2008-02-28 |
Signal Pharmaceuticals, Llc |
Combination therapy for treating, preventing or managing proliferative disorders and cancers
|
SE0201863D0
(en)
|
2002-06-18 |
2002-06-18 |
Cepep Ab |
Cell penetrating peptides
|
CA2496400A1
(en)
|
2002-09-09 |
2004-03-18 |
Dana-Farber Cancer Institute, Inc. |
Bh3 peptides and method of use thereof
|
PL374700A1
(en)
*
|
2002-09-20 |
2005-10-31 |
Alcon, Inc. |
Use of cytokine synthesis inhibitors for the treatment of dry eye disorders
|
PT1408114E
(pt)
|
2002-10-11 |
2007-04-30 |
Imvision Gmbh |
Moléculas modulares de transportes de antigénios ( moléculas mat ) para modulação de respostas imunitárias, correspondentes construções, processos e utilizações.
|
WO2004037196A2
(en)
|
2002-10-24 |
2004-05-06 |
Sangstat Medical Corporation |
Cytomodulating peptides and methods for treating neurological disorders
|
EP1578365A4
(de)
|
2002-11-14 |
2009-09-23 |
Arbor Vita Corp |
Molekulare interaktionen in neuronen
|
AU2003294312A1
(en)
|
2002-11-18 |
2004-07-09 |
Celgene Corporation |
Methods of usig and compositions comprising (-)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide
|
US20050019366A1
(en)
|
2002-12-31 |
2005-01-27 |
Zeldis Jerome B. |
Drug-coated stents and methods of use therefor
|
US7166692B2
(en)
|
2003-03-04 |
2007-01-23 |
Canbrex Bio Science Walkersville, Inc. |
Intracellular delivery of small molecules, proteins, and nucleic acids
|
EP2295433A3
(de)
*
|
2003-03-06 |
2011-07-06 |
Eisai R&D Management Co., Ltd. |
JNK Inhibitoren
|
WO2004092339A2
(en)
|
2003-04-11 |
2004-10-28 |
Ilex Products, Inc. |
Modulation of muc1 mediated signal transduction
|
WO2004097017A2
(en)
*
|
2003-04-29 |
2004-11-11 |
Avi Biopharma, Inc. |
Compositions for enhancing transport and antisense efficacy of nucleic acid analog into cells
|
WO2005084158A2
(en)
|
2003-06-20 |
2005-09-15 |
The Regents Of The University Of California |
Polypeptide transduction and fusogenic peptides
|
KR100685345B1
(ko)
|
2004-03-27 |
2007-02-22 |
학교법인조선대학교 |
세포사 유도 펩타이드
|
US20080039377A1
(en)
*
|
2004-04-08 |
2008-02-14 |
Applied Research Systems Ars Holding N.V. |
Composition Comprising a Jnk Inhibitor and Cyclosporin
|
EP1786781A2
(de)
|
2004-08-27 |
2007-05-23 |
GPC Biotech AG |
Pyrimidinderivate
|
US20060094753A1
(en)
|
2004-10-29 |
2006-05-04 |
Alcon, Inc. |
Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases
|
EP1656951A1
(de)
|
2004-11-12 |
2006-05-17 |
Xigen S.A. |
Konjugate mit verbesserter Zellaufnahme
|
EP1676574A3
(de)
|
2004-12-30 |
2006-07-26 |
Johnson & Johnson Vision Care, Inc. |
Verfahren zur Förderung des Überlebens von Zell- und Gewebe-Transplantaten
|
US20060223807A1
(en)
*
|
2005-03-29 |
2006-10-05 |
University Of Massachusetts Medical School, A Massachusetts Corporation |
Therapeutic methods for type I diabetes
|
US20070015779A1
(en)
|
2005-04-29 |
2007-01-18 |
John Griffin |
Compositions and treatments for inhibiting kinase and/or hmg-coa reductase
|
WO2006130297A2
(en)
*
|
2005-04-29 |
2006-12-07 |
Celgene Corporation |
Solid forms of 1-( 5-(ih-i , 2 , 4 -triazol- 5 -yl)(1h-indazol-3-yl))-3-(2-piperidylethoxy)benzene
|
US20070003531A1
(en)
*
|
2005-06-30 |
2007-01-04 |
University Of Connecticut |
Methods for improving immunotherapy by enhancing survival of antigen-specific cytotoxic T lymphocytes
|
US8080517B2
(en)
*
|
2005-09-12 |
2011-12-20 |
Xigen Sa |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
WO2007031098A1
(en)
*
|
2005-09-12 |
2007-03-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the jnk signal transduction pathway
|
WO2008006046A1
(en)
*
|
2006-07-06 |
2008-01-10 |
Case Western Reserve University |
Ceramide composition and use thereof in treatment of ocular diseases
|
US20080051410A1
(en)
|
2006-08-02 |
2008-02-28 |
Northwestern University |
Protein Kinase Targeted Therapeutics
|
KR101177729B1
(ko)
|
2006-09-08 |
2012-09-07 |
에프. 호프만-라 로슈 아게 |
벤조트리아졸 키나아제 조절제
|
GB0702259D0
(en)
|
2007-02-06 |
2007-03-14 |
Eisai London Res Lab Ltd |
7-azaindole derivatives
|
ES2530723T3
(es)
|
2008-05-07 |
2015-03-04 |
Univ California |
Reposición y enriquecimiento terapéuticos de la lubricación de la superficie ocular
|
WO2009143864A1
(en)
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
|
WO2009143865A1
(en)
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
US20100183633A1
(en)
|
2008-12-04 |
2010-07-22 |
University Of Massachusetts |
Interleukin 6 and tumor necrosis factor alpha as biomarkers of jnk inhibition
|
EA201171188A1
(ru)
|
2009-03-30 |
2012-05-30 |
Сантен Фармасьютикал Ко., Лтд. |
Профилактическое или терапевтическое средство против болезни сетчатки и способ профилактики или лечения болезни сетчатки с использованием jnk (c-jun-аминоконцевая киназа)-ингибиторного пептида, а также применение указанного пептида
|
WO2011160653A1
(en)
|
2010-06-21 |
2011-12-29 |
Xigen S.A. |
Novel jnk inhibitor molecules
|
ES2575226T3
(es)
|
2010-10-14 |
2016-06-27 |
Xigen Inflammation Ltd. |
Péptidos permeables celulares inhibidores de la ruta de transducción de la señal JNK para su uso en el tratamiento de la uiveítis
|
JP5857056B2
(ja)
|
2010-10-14 |
2016-02-10 |
ザイジェン インフラメーション エルティーディー |
慢性又は非慢性の炎症性眼疾患を治療するためのjnkシグナル伝達経路の細胞透過性ペプチド阻害剤の使用
|
US8471027B2
(en)
|
2011-04-06 |
2013-06-25 |
Hoffmann-La Roche Inc. |
Adamantyl compounds
|
WO2013091670A1
(en)
|
2011-12-21 |
2013-06-27 |
Xigen S.A. |
Novel jnk inhibitor molecules for treatment of various diseases
|
WO2014206426A1
(en)
|
2013-06-26 |
2014-12-31 |
Xigen Inflammation Ltd. |
New use for jnk inhibitor molecules for treatment of various diseases
|